GDF11 alleviates spinal cord injury in rats by modulating microglia polarization through Smad2/3 and MAPK/NFκB signaling pathways
International Immunopharmacology · 2025-10 · 163 · 115197
DOI: 10.1016/j.intimp.2025.115197 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-10. Verfasst von Zihao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China; School of Clinical…. Hauptthemen laut MEDLINE: Microglia, Spinal Cord Injuries, Growth Differentiation Factors, Bone Morphogenetic Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Inflammatory response after spinal cord injury is an important factor in further exacerbating the extent of spinal cord injury. The polarization of microglia plays a pivotal role in the inflammatory cascade after SCI. This study investigated whether exogenous Growth Differentiation Factor 11 (GDF11) mitigates neuroinflammation and improves functional recovery by modulating M1/M2 microglial polarization, exploring its therapeutic potential for SCI. METHODS: The protective and anti-inflammatory effect of GDF11 on LPS-induced microglia polarization was examined in vitro study. An Allen model of spinal cord injury was established to detect the therapeutic effects of GDF11. Transcriptome sequencing elucidated GDF11's downstream pathways. RESULTS: GDF11 effectively improved histological and functional recovery in SCI rats. In vitro studies we found that GDF11 improved LPS-mediated M1 polarization state of microglia and was able to promote the conversion of M1 macrophages to M2 macrophages. The anti-inflammatory effects of GDF11 were associated with the activation of the TGF-β signaling pathway and the inhibition of MAPK and NF-κB activation. CONCLUSION: The present study reveals that GDF11 alleviates secondary injury after SCI by reprogramming microglial polarization, highlighting its promise as a novel therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China; School of Clinical Medicine, Shandong University, Jinan, China; School of Clinical Medic…
- School of Clinical Medicine, Shandong University, Jinan, China.
- Qingdao Central Hospital, University of Health and Rehabilitation Sciences(Qingdao Central Hospital).
- Department of Orthopaedic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China; School of Clinical Medicine, Shandong University, Jinan, China.
- Department of Radiology, Second hospital of Shan Dong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250033, China. Electronic address: jingr117@126.com.
- Department of Orthopaedic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China. Electronic address: cong@email.sdu.edu.cn.
Förderung
- Shandong Province Natural Science Foundation
Zitieren
APA
Wang, Z., Zhang, Y., Liu, W., Liu, K., Wang, S., Jing, R., & Cong, M. (2025). GDF11 alleviates spinal cord injury in rats by modulating microglia polarization through Smad2/3 and MAPK/NFκB signaling pathways. International Immunopharmacology, 163, 115197. https://doi.org/10.1016/j.intimp.2025.115197
Vancouver
Wang Z, Zhang Y, Liu W, Liu K, Wang S, Jing R, et al. GDF11 alleviates spinal cord injury in rats by modulating microglia polarization through Smad2/3 and MAPK/NFκB signaling pathways. International Immunopharmacology. 2025;163:115197. doi:10.1016/j.intimp.2025.115197
BibTeX
@article{Wang2025,
author = {Wang, Zihao and Zhang, Yuxuan and Liu, Wei and Liu, Kaiwen and Wang, Shaoyi and Jing, Rui and Cong, Menglin},
title = {GDF11 alleviates spinal cord injury in rats by modulating microglia polarization through Smad2/3 and MAPK/NFκB signaling pathways},
journal = {International Immunopharmacology},
year = {2025},
volume = {163},
pages = {115197},
doi = {10.1016/j.intimp.2025.115197}
}
EUVIMED